Indian equity markets are poised for a potential rally driven by strong corporate earnings and resilient consumer demand, according to market expert Sandip Sabharwal. He believes a resolution to West Asia tensions could lead to a sharp correction in crude oil prices, further boosting sentiment. Sabharwal anticipates markets could reach new highs if geopolitical stability returns and earnings momentum continues.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026